Replies to post #754096 on NorthWest Biotherapeutics Inc (NWBO)

[KRISGO]

Yes, how are they making money without DCVAX-L approved? Or is it from DCVAX-L compassionate care funds? or from other parties? How will this benefit NWBO shareholders?

Advent Bio revenue up 23% between 2022 and 2023, as filed on March 4, 2025.
💪
Revenue is likely from the UK Specials Programme to produce DCVax-L. Can't wait to see the 2024 numbers, as they will likely be significant.
👍